ITMI921720A1 - Fosforotidati di oligonucleotidi ciclici - Google Patents

Fosforotidati di oligonucleotidi ciclici

Info

Publication number
ITMI921720A1
ITMI921720A1 IT001720A ITMI921720A ITMI921720A1 IT MI921720 A1 ITMI921720 A1 IT MI921720A1 IT 001720 A IT001720 A IT 001720A IT MI921720 A ITMI921720 A IT MI921720A IT MI921720 A1 ITMI921720 A1 IT MI921720A1
Authority
IT
Italy
Prior art keywords
phosphorotidates
cyclic oligonucleotides
oligonucleotides
cyclic
oligonucleotides phosphorotidates
Prior art date
Application number
IT001720A
Other languages
English (en)
Inventor
Carlo Battistini
Maria Gabriella Brasca
Giovanni Battista Colombo
Silvia Fustinoni
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ITMI921720A0 publication Critical patent/ITMI921720A0/it
Publication of ITMI921720A1 publication Critical patent/ITMI921720A1/it
Application granted granted Critical
Publication of IT1255222B publication Critical patent/IT1255222B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ITMI921720A 1991-07-18 1992-07-15 Fosforotidati di oligonucleotidi ciclici IT1255222B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9115586A GB2257704B (en) 1991-07-18 1991-07-18 Cyclic oligonucleotides phosphorothioates

Publications (3)

Publication Number Publication Date
ITMI921720A0 ITMI921720A0 (it) 1992-07-15
ITMI921720A1 true ITMI921720A1 (it) 1994-01-15
IT1255222B IT1255222B (it) 1995-10-20

Family

ID=10698606

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921720A IT1255222B (it) 1991-07-18 1992-07-15 Fosforotidati di oligonucleotidi ciclici

Country Status (5)

Country Link
US (1) US5547941A (it)
JP (1) JPH05186495A (it)
DE (1) DE4223438A1 (it)
GB (1) GB2257704B (it)
IT (1) IT1255222B (it)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390441A1 (en) * 1999-11-08 2001-05-17 Origenix Technologies, Inc. Combinatorial library synthesis and pharmaceutically active compounds produced thereby
KR20020069627A (ko) * 2001-02-27 2002-09-05 동부한농화학 주식회사 육환의 아자슈거를 가진 뉴클레오타이드 유도체를 포함한포스포로티오에이트 올리고뉴클레오타이드 및 이들의에이즈 치료제로서의 새로운 용도
US6881831B2 (en) * 2001-05-16 2005-04-19 Migenix Inc. Nucleic acid-based compounds and methods of use thereof
US7345163B2 (en) * 2002-08-28 2008-03-18 Quiatech Ab Process for separating and deprotecting oligonucleotides
EP1651242A2 (en) 2003-07-28 2006-05-03 David K. R. Karaolis Method for attenuating virulence of microbial pathogens and for inhibiting microbial biofilm formation
US20070149451A1 (en) * 2003-11-17 2007-06-28 Holmes David G Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
JP4887284B2 (ja) * 2004-03-15 2012-02-29 デイビッド・ケイ・アール・カラオリス 癌細胞の増殖を阻害するための、または癌細胞のアポトーシスを増大させるための方法
EP1782826A1 (en) * 2005-11-08 2007-05-09 GBF Gesellschaft für Biotechnologische Forschung mbH PQS and c-diGMP and its conjugates as adjuvants and their uses in pharmaceutical compositions
WO2009133560A1 (en) * 2008-04-29 2009-11-05 Smart Assays Non-hydrolyzable and permeable cyclic bis-[nucleotide monophosphate] derivatives and uses thereof
CN102199183B (zh) * 2010-03-26 2013-12-18 北京大学 环二鸟苷酸及其类似物和制备方法
EP2858722B8 (en) 2012-06-08 2018-02-21 Aduro BioTech, Inc. Compostions and methods for cancer immunotherapy
HUE043262T2 (hu) * 2012-12-13 2019-08-28 Aduro Biotech Inc Meghatározott sztereokémiájú ciklikus purindinukleotidokat tartalmazó készítmények, valamint eljárások elõállításukra és alkalmazásukra
WO2014109256A1 (ja) * 2013-01-09 2014-07-17 国立大学法人東北大学 トリアゾール連結型環状ジヌクレオチド類縁体
EA201592074A1 (ru) 2013-04-29 2016-02-29 Мемориал Слоан Кеттеринг Кэнсер Сентер Композиции и способы изменения сигнальной системы вторичного мессенджера
ES2822584T3 (es) 2013-05-03 2021-05-04 Univ California Inducción de dinucleótidos cíclicos del interferón tipo I
US9549944B2 (en) 2013-05-18 2017-01-24 Aduro Biotech, Inc. Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
JP6453855B2 (ja) 2013-05-18 2019-01-16 アドゥロ バイオテック，インク． 「インターフェロン遺伝子の刺激因子」依存性シグナル伝達を活性化するための組成物及び方法
EP3027227A4 (en) 2013-07-31 2018-05-23 Memorial Sloan Kettering Cancer Center Sting crystals and modulators
ES2692226T3 (es) 2014-06-04 2018-11-30 Glaxosmithkline Intellectual Property Development Limited Dinucleótidos cíclicos como moduladores de STING
GB201501462D0 (en) 2015-01-29 2015-03-18 Glaxosmithkline Ip Dev Ltd Novel compounds
JP6692826B2 (ja) 2015-03-10 2020-05-13 アドゥロ バイオテック，インク． 「インターフェロン遺伝子刺激因子」依存性シグナル伝達の活性化のための組成物及び方法
EP3322713B1 (en) 2015-12-03 2021-01-20 GlaxoSmithKline Intellectual Property Development Limited Cyclic purine dinucleotides as modulators of sting
EP3507367A4 (en) 2016-07-05 2020-03-25 Aduro BioTech, Inc. CYCLIC DINUCLEOTID COMPOUNDS WITH INCLUDED NUCLEIC ACIDS AND USES THEREOF
JP7100227B2 (ja) * 2016-07-06 2022-07-13 エフ－スター・セラピューティクス・インコーポレイテッド 疾患の治療のための化合物、組成物、および方法
US10266558B2 (en) * 2016-10-07 2019-04-23 Alexandre Vasilievich Ivachtchenko Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof
JOP20170192A1 (ar) 2016-12-01 2019-01-30 Takeda Pharmaceuticals Co داي نوكليوتيد حلقي
US20200055883A1 (en) 2017-02-17 2020-02-20 Eisai R&D Management Co., Ltd. Cyclic di-nucleotides derivative for the treatment of cancer
US11584774B2 (en) 2017-09-11 2023-02-21 F-star Therapeutics, Inc. Compounds, compositions, and methods for the treatment of disease
US11707531B2 (en) 2017-09-11 2023-07-25 F-star Therapeutics, Inc. Compounds, compositions, and methods for the treatment of disease
BR112020009126A2 (pt) 2017-11-10 2020-10-20 Takeda Pharmaceutical Company Limited compostos do modulador sting e métodos de fabricação e uso
KR20210015937A (ko) 2018-06-01 2021-02-10 에자이 알앤드디 매니지먼트 가부시키가이샤 방광암을 치료하기 위한 방법
EP3837268A4 (en) 2018-08-16 2022-04-20 Eisai R&D Management Co., Ltd. SALTS OF COMPOUNDS AND CRYSTALS THEREOF
CN114127082A (zh) 2019-05-09 2022-03-01 阿里戈斯治疗公司 作为sting调节剂的经修饰的环状二核苷化合物
TW202227099A (zh) * 2020-10-20 2022-07-16 大陸商泰勵生物科技（上海）有限公司 多功能環二核苷酸及其用途
PE20231947A1 (es) 2020-11-09 2023-12-05 Takeda Pharmaceuticals Co Conjugados de anticuerpo y farmaco

Also Published As

Publication number Publication date
JPH05186495A (ja) 1993-07-27
IT1255222B (it) 1995-10-20
DE4223438A1 (de) 1993-01-21
GB9115586D0 (en) 1991-09-04
GB2257704B (en) 1995-03-01
GB2257704A (en) 1993-01-20
ITMI921720A0 (it) 1992-07-15
US5547941A (en) 1996-08-20

Similar Documents

Publication Publication Date Title
ITMI921720A1 (it) Fosforotidati di oligonucleotidi ciclici
FI922424A (fi) Kemiska foereningar
DE69217696D1 (de) Zahnbürste
FI935005A0 (fi) Kylcontainer
FI922964A (fi) Cykliska imidderivat
FI923429A (fi) Bigaggregat
ATA131391A (de) Reibring
FI925532A (fi) Agrikemisk blandningskombination
ITRM910890A0 (it) Nuovi oligonucleotidi antisenso
BR9204511A (pt) Recolhedor-enrolador
FI931641A0 (fi) Klar, hydrofilisk belaeggning foer vaermevaemlares flaensar
DE69218229D1 (de) Entschwefelungsbehandlung
FI920876A (fi) Vaevd elvaermare
FI925016A (fi) Tvaokomponentsystem foer oeverdragning
FI923224A (fi) Oeppnande aendvaegg foer sluten dubbeldaeckad jaernvaegsgodsvagn
FI933900A (fi) Heterocykliska foereningar
FI934866A (fi) Liposomala polysackaridvacciner
ATA170491A (de) Mauerstein
DE69126968T2 (de) Tamburin
NO922774D0 (no) Kinolin-2-yl-metoksybenzylhydroksyurinstoff
FI934935A (fi) Maetcell foer elektrokinetisk potential
ITMI912117A0 (it) Oligonucleotidi antisenso
FI924076A0 (fi) Cykliska nitroner.
ITBZ910022A1 (it) Dissolutore fisico
FI925389A (fi) Bensokinoxaliner

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950628